PHOENIX/DETROIT/MUMBAI: Unlike other weekends, this one was an exceptionally busy one at Ash Stevens — Piramal Pharma 's acquisition in the resurgent Detroit. The firm was going live with new enterprise software to eventually integrate with Piramal Pharma. "Integrating American and Indian cultures is probably one of the most engaging parts of my job," says Michael Jordan, head of HR, Piramal Pharma Solutions. From the Rs 15,000 crore it received from Abbott, Rs 6,000 crore was invested in the pharma segment. Within global pharma, we expect to be 20-25% over the next three years," says Nandini.

Source: Economic Times February 12, 2018 17:57 UTC